Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
Phio Pharmaceuticals appointed Dr. R. Todd Plott, M.D., a board-certified dermatologist and former FDA advisory committee member, to its Board of Directors. Dr.
Key figures
- Drug Name
- PH-762
- Phase Of Trial
- Phase 1b
- Nct number
- 06014086
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.